Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Hedge Funds Eye Biopharma IPO
Stephen Taub
March 26, 2024
After a Lousy 2023, Managed Futures Funds Are on the Rebound
Stephen Taub
March 25, 2024
Premium
The Red-Hot AI Stock Hedgies Missed
Stephen Taub
March 21, 2024
Bridgewater’s Gains in the First Two Months of 2024 Cover Last Year’s Losses
Stephen Taub
March 20, 2024
Inside the Performance of Tiger Management Descendants So Far in 2024
Stephen Taub
March 19, 2024
Premium
Biopharma Funds Continue to Surge
Stephen Taub
March 18, 2024
Premium
Icahn’s Hedge Fund Posts a Huge Loss for 2023
Stephen Taub
March 14, 2024
Why Jericho Is Surging
Stephen Taub
March 13, 2024
Greenlight Posts a Loss in February
Stephen Taub
March 12, 2024
Third Point’s ‘Magnificent’ February
Stephen Taub
March 11, 2024
Premium
Light Street’s AI-Focused Hedge Fund Continues Its Streak
Stephen Taub
March 7, 2024
Premium
Valiant Surges in January
Stephen Taub
February 22, 2024
Premium
Life Sciences Hedge Funds May Have Moved Past One of Their Worst Stretches
Stephen Taub
February 21, 2024
Premium
Druckenmiller Dumps Two High-Profile Tech Stocks
Stephen Taub
February 20, 2024
Premium
Here Are the Funds With a Tiger Pedigree That Made the Biggest Moves Last Quarter
Stephen Taub
February 15, 2024
Premium
Why Tiger Cub Discovery Is Bullish
Stephen Taub
February 13, 2024
Premium
Biopharma’s Boom and Bust
Stephen Taub
February 12, 2024
Behind VR Global’s Big Argentinian Bet
Stephen Taub
February 8, 2024
More Articles